GAMMA BIOLOGICALS NAMES JOHN J. MOULDS PRESIDENT
GAMMA BIOLOGICALS NAMES JOHN J. MOULDS PRESIDENT HOUSTON, June 9 /PRNewswire/ -- The Gamma Biologicals, Inc.
(AMEX: GBL) board of directors announced today that it has appointed John J. Moulds president and chief operating officer. Previously, he was executive vice president and COO. David E. Hatcher remains chairman and chief executive officer.
Moulds joined Gamma in 1975 as director of consultation & education and was named COO in 1988. Currently, he manages both the monoclonal reagent and bioelectrical sensor programs. Moulds earned a BA in biology and chemistry from Chadron State College, Chadron, Neb., and a medical technology (MT) degree from St. John's Hospital, Rapid City, S.D. He received his specialist in blood banking (SBB) from War Memorial Blood Bank, Minneapolis, in 1969, and he served as director of the consultation service there until joining Gamma. Well recognized within the profession, he has served as chairman of the International Society of Blood Transfusion's (ISBT) Committee for Blood Group Nomenclature and chairman of the rare donor file of the American Association of Blood Banks (AABB). Moulds founded the International Exchange of Rare Blood Specimens. Gamma Biologicals manufactures and markets a wide range of highly refined and specialized testing products, known as diagnostic reagents, as well as sophisticated instrument systems. The company markets to hospitals, blood banks, medical laboratories, physicians' offices and research institutions. -0- 6/9/92 /CONTACT: David E. Hatcher, chairman of Gamma Biologicals, 713-660-7990/ (GBL) CO: Gamma Biologicals, Inc. ST: Texas IN: MTC SU: PER
TS -- NY042 -- 8379 06/09/92 12:36 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Jun 9, 1992|
|Previous Article:||TRACOR RECEIVES $8.2 MILLION NAVY CONTRACT|
|Next Article:||LOGICON AWARDED CONTRACT FOR MILSTAR INDEPENDENT SECURITY VALIDATION AND VERIFICATION SUPPORT|